Nephrotoxic effects of varenicline as the most effective drug used for smoking cessation: A preliminary experimental study

dc.authorid0000-0001-5549-3883en_US
dc.contributor.authorKoç, Akif
dc.contributor.authorErken, Haydar Ali
dc.contributor.authorKoçak, Fatma Emel
dc.contributor.authorYay, Arzu
dc.contributor.authorGüçlü, Aydin
dc.contributor.authorSarı, Erhan
dc.contributor.authorŞimşek, Hasan
dc.contributor.authorÖnder, Gözde Özge
dc.date.accessioned2019-10-17T10:29:57Z
dc.date.available2019-10-17T10:29:57Z
dc.date.issued2015en_US
dc.departmentFakülteler, Tıp Fakültesi, Temel Tıp Bilimleri Bölümüen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümüen_US
dc.descriptionKoç, Akif (Balikesir Author)en_US
dc.description.abstractVarenicline is a new most effective drug for smoking cessation. Its effect on kidney functions remains unclear. This study purposed to investigate whether varenicline causes nephrotoxicity in rats. Fifteen rats were randomly assigned to three groups: control, 0.0125 mg kg(-1) varenicline and 0.025 mg kg(-1) varenicline (single dose for 3 days, i.p.). Before and after experimental period, serum neutrophil gelatinase-associated lipocalin, creatinine and urea levels were measured. Total oxidant and antioxidant status were measured in kidney homogenates. Histological examination was performed in kidney. The nephrotoxic effects of varenicline were detected by histopathological and biochemical examinations in the varenicline treatment groups. No change was observed in the control group. These findings firstly indicate that a 3-day varenicline treatment causes nephrotoxic effects in rats.en_US
dc.identifier.doi10.1007/s11255-015-0949-5
dc.identifier.endpage829en_US
dc.identifier.issn0301-1623
dc.identifier.issn1573-2584
dc.identifier.issue5en_US
dc.identifier.scopus2-s2.0-84939956617
dc.identifier.scopusqualityQ2
dc.identifier.startpage823en_US
dc.identifier.urihttps://doi.org/10.1007/s11255-015-0949-5
dc.identifier.urihttps://hdl.handle.net/20.500.12462/8100
dc.identifier.volume47en_US
dc.identifier.wosWOS:000353826400019
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Urology and Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectCreatinineen_US
dc.subjectKidneyen_US
dc.subjectNephrotoxicityen_US
dc.subjectNeutrophil Gelatinase-Associated Lipocalinen_US
dc.subjectUreaen_US
dc.subjectVareniclineen_US
dc.titleNephrotoxic effects of varenicline as the most effective drug used for smoking cessation: A preliminary experimental studyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
akif-koc.pdf
Boyut:
860.84 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: